high-dose riboflavin (10 mg kg 1 day 1 ) or flavin esters rapidly restore ATP production and cell viability in vitro ( SLC52A3 knock-down and SLC52A3 / mice recapitulate hearing loss, ataxia and early death, all of which improve with systemic riboflavin supplementation ( SLC52A2 gene replacement normalized FMN/FAD levels, rescued spinal motor neurons and reversed motor deficits when delivered pre-symptomatically, underscoring the feasibility of curative therapy ( Clinically, oral or intravenous riboflavin remains first-line treatment
Katturajan R, Nithiyanandam S, Parthasarathy M, Gopalakrishnan AV, Sathiyamoorthi E, Lee J
Rahman I, Smith CA, Lawson MF, Harrison DJ, MacNee W: Induction of gamma-glutamylcysteine synthetase by cigarette smoke is associated with AP-1 in human alveolar epithelial cells
JHU does offer financial aid for commuting and online programs